Joseph Ciaffoni, President and CEO at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 43 shares at $22.00 ($946) on 2022-11-28, disclosed to the SEC on 2022-11-30.
Scheduled sale ($946) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| COLL | SELL | 2023-06-02 | $2.7M | — | Filing → |
| COLL | SELL | 2023-06-01 | $2.7M | — | Filing → |
| COLL | SELL | 2023-02-14 | $302K | — | Filing → |